Stocks Health care ISRG
NASDAQ · Health careIntuitive Surgical Inc (ISRG)
Intuitive Surgical Inc brought in $11B of revenue over the twelve months to June 30, 2026, up 20.7% from a year earlier. Net income was $3.1B, a net margin of 28.4%. Operating cash flow minus capital spending left $2.5B of free cash flow in fiscal 2025. At June 30, 2026 it held $2.8B in cash. Its latest periodic report to the SEC is the quarterly report (10-Q) filed on July 21, 2026.
Key facts about Intuitive Surgical Inc
- Net worth
- Intuitive Surgical Inc has a market value (market cap) of $150.8B at the latest share price, and shareholders' equity of $18.2B on its balance sheet at June 30, 2026. A company's "net worth" usually means one of these: what the market pays for all its shares, or its assets minus its liabilities.
- Revenue and profit
- In fiscal 2025 revenue was $10.1B (+20.5% year on year), with net income of $2.9B. Over the 12 months to June 30, 2026: revenue $11B, net income $3.1B.
- Cash flow
- In fiscal 2025 operations brought in $3B of cash; after $539.8M of capital spending, free cash flow was $2.5B.
- Latest report
- The latest periodic report (quarterly report, 10-Q) was filed with the SEC on July 21, 2026 and covers the period to June 30, 2026. Open on SEC EDGAR
- Next earnings report
- Intuitive Surgical Inc's next report is expected around October 20, 2026. That is an estimate from its filing rhythm, not a date the company has announced.
What Intuitive Surgical Inc does
Intuitive Surgical designs, manufactures, and markets robotic-assisted surgical systems, most notably the da Vinci Surgical System. It also sells surgical instruments, accessories, and maintenance services. Its customers are hospitals, surgery centers, and healthcare providers. Its shares trade on NASDAQ under the ticker ISRG.
Revenue and profit by year
Key figures
| Fiscal year | Revenue | Net income | Diluted EPS | Free cash flow |
|---|---|---|---|---|
| 2025 | $10.1B | $2.9B | $7.87 | $2.5B |
| 2024 | $8.4B | $2.3B | $6.42 | $1.3B |
| 2023 | $7.1B | $1.8B | $5.03 | $749.6M |
| 2022 | $6.2B | $1.3B | $3.65 | $958.4M |
| 2021 | $5.7B | $1.7B | $4.66 | $1.7B |
| 2020 | $4.4B | $1.1B | $2.94 | $1.1B |
Earnings: every quarter and the next report date
Full financial statements: income, balance sheet and cash flow
Where ISRG ranks in Health care
Latest SEC filings
What Intuitive Surgical Inc has filed recently, newest first. Each links to the original document on SEC EDGAR.
- July 27, 2026
- July 21, 2026
- July 21, 2026Quarterly report 10-Q · period to June 30, 2026Revenue rose 19% to $2.9B versus the same quarter last year; diluted EPS $2.29 versus $1.81.
- July 16, 2026
- May 28, 2026
- May 21, 2026
- May 4, 2026
- April 30, 2026Passive stake (5% or more) SCHEDULE 13G
- April 22, 2026Quarterly report 10-Q · period to March 31, 2026Revenue rose 23% to $2.8B versus the same quarter last year; diluted EPS $2.28 versus $1.92.
- April 21, 2026
What is ISRG worth? A DCF from its reported cash flow
Insider trades
What the people running Intuitive Surgical Inc did with its shares, from the Form 4 filings they must send the SEC within two business days.
Insiders sold $5M worth of shares in the last 90 days and bought none on the open market. All of the selling was pre-planned under Rule 10b5-1 trading plans.
| Date | Insider | What | Shares | Value |
|---|---|---|---|---|
| September 15, 2026 | Widman FredrikVP Corporate Controller | Exercised options | 546 | $43.5K |
| September 15, 2026 | Widman FredrikVP Corporate Controller | Soldpre-planned (10b5-1) | 546 | $204.4K |
| September 15, 2026 | Widman FredrikVP Corporate Controller | Exercised options | 543 | $59.5K |
| September 15, 2026 | Widman FredrikVP Corporate Controller | Soldpre-planned (10b5-1) | 543 | $203.3K |
| September 11, 2026 | Brosius MarkEVP & Chief Mfg and Supply Cha | Soldpre-planned (10b5-1) | 25 | $9.1K |
| September 10, 2026 | Brosius MarkEVP & Chief Mfg and Supply Cha | Soldpre-planned (10b5-1) | 23 | $8K |
| September 9, 2026 | Brosius MarkEVP & Chief Mfg and Supply Cha | Soldpre-planned (10b5-1) | 23 | $8.1K |
| September 8, 2026 | Brosius MarkEVP & Chief Mfg and Supply Cha | Soldpre-planned (10b5-1) | 46 | $16.6K |
Who owns ISRG
Three views from three kinds of SEC filings, each with its own date. They overlap and are not added up.
5% holders
| Holder | Of class | Filed |
|---|---|---|
| Vanguard Capital Management13G, passive | 7.49% | April 30, 2026 |
Largest institutional holders
Positions that investment managers reported on Form 13F for the quarter ended June 30, 2026, largest first, with the change on the quarter ended March 31, 2026. Managers file 13F up to 45 days after a quarter ends. 2,247 managers reported a position.
| Holder | Shares | Change on quarter |
|---|---|---|
| BlackRock, Inc. | 30,024,648 | -51,257 |
| Vanguard Capital Management LLC | 23,131,099 | +51,609 |
| State Street Corp | 16,063,040 | +216,067 |
| Invesco Ltd. | 11,843,563 | +653,078 |
| Geode Capital Management, LLC | 8,534,767 | +67,916 |
| Capital World Investors | 7,742,681 | -305,329 |
| Vanguard Portfolio Management LLC | 7,243,264 | +9,293 |
| Morgan Stanley | 6,561,322 | +502,482 |
| Norges Bank | 4,954,874 | new |
| Jpmorgan Chase & Co | 4,231,033 | -362,861 |
| Fmr LLC | 4,251,130 | -1,226,104 |
| Alliancebernstein L.P. | 3,632,766 | -179,897 |
| Fisher Asset Management, LLC | 3,918,840 | +65,900 |
| Wellington Management Group Llp | 3,802,003 | -157,287 |
| Arrowstreet Capital, Limited Partnership | 3,744,497 | +1,638,953 |
| Jennison Associates LLC | 3,669,211 | +628,201 |
| Northern Trust Corp | 3,512,996 | +8,724 |
| Bank of America Corp | 3,403,759 | -213,214 |
| Bank of New York Mellon Corp | 3,358,863 | -191,512 |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC | 3,268,066 | -48,192 |
Insiders
19 insiders reported holding 1,621,856 shares in total, about $692.4M at the last price.
| Holder | Shares |
|---|---|
| Guthart Gary SDirector | 1,269,4681,245,679 held indirectly |
| Rosa David J.Chief Executive Officer (CEO), Director | 246,856 |
| Barratt Craig HDirector | 27,94827,948 held indirectly |
| Samath JamieEVP & CFO & Enterprise Technol | 15,366 |
| Johnson Amal MDirector | 13,545 |
| Charlton Henry LEVP & Chief Commercial and Mkt | 11,610 |
| Nachtsheim Jami KDirector | 6,902 |
| Jeddi ImanSVP & GM da Vinci Platforms & | 6,463 |
| Miller Brian EdwardEVP & Chief Digital Officer | 5,758 |
| Loeb GaryEVP & Chief Legal and Complian | 5,320 |
Questions about ISRG
What does Intuitive Surgical Inc do?
Intuitive Surgical designs, manufactures, and markets robotic-assisted surgical systems, most notably the da Vinci Surgical System. It also sells surgical instruments, accessories, and maintenance services. Its customers are hospitals, surgery centers, and healthcare providers. Its shares trade on NASDAQ under the ticker ISRG.
What is Intuitive Surgical Inc's net worth?
Intuitive Surgical Inc has a market value (market cap) of $150.8B at the latest share price, and shareholders' equity of $18.2B on its balance sheet at June 30, 2026. A company's "net worth" usually means one of these: what the market pays for all its shares, or its assets minus its liabilities.
Is Intuitive Surgical Inc profitable?
Yes. Over the twelve months to June 30, 2026 it reported net income of $3.1B on revenue of $11B, a net margin of 28.4%.
How much revenue does Intuitive Surgical Inc make?
Over the twelve months to June 30, 2026 Intuitive Surgical Inc reported revenue of $11B. That is 20.7% more than a year earlier.
When did Intuitive Surgical Inc last report?
Its most recent periodic report is the quarterly report (10-Q) filed on July 21, 2026. It covers the period to June 30, 2026. Its newest filing of any kind is the insider trade from September 16, 2026.
When is Intuitive Surgical Inc's next earnings report?
Intuitive Surgical Inc's next report is expected around October 20, 2026. That is an estimate from its filing rhythm, not a date the company has announced.
Similar companies
Compare ISRG with
Follow ISRG
Get an email when Intuitive Surgical Inc files with the SEC: results, executive changes, material agreements and annual reports.
Where the numbers come from
Financial figures are the values Intuitive Surgical Inc tagged in its own SEC filings (XBRL), taken from the latest filing for each period, so restatements replace older figures. Revenue, profit and cash flow are for full fiscal years unless marked as the last twelve months, which is the sum of the four most recent quarters. Where a company reports only the full year, the fourth quarter is the year minus the first three.
Prices are delayed end-of-day market data in the listing currency, and market cap moves with the price. P/E is shown only when earnings per share are positive. Nothing here is investment advice.